Baird Medical Investment Holdings Limited(BDMD)

Medical - Devices · Guangzhou, GD

$0.78+0.04 (+5.01%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Baird Medical Investment Holdings (BDMD) Price/Sales Ratio: History & Chart | TGMCharts

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T22:55:45.792Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:55:45.792Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 32,927,056
TTM revenue · period ending 2026-06-30: N/A

FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BDMD PS Ratio Metrics

PS RATIO

N/A

BDMD Competitors' PS Ratio

BDMD

Baird Medical Investment Holdings Limited

Current

Market Cap

$32.93M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEPH

Nephros, Inc.

vs BDMD

Market Cap

$32.79M

PS Ratio

1.58

TTM Avg

2.43

3Y Avg

1.99

5Y Avg

2.26

ALGS

Aligos Therapeutics, Inc.

vs BDMD

Market Cap

$33.29M

PS Ratio

1.06

TTM Avg

22.78

3Y Avg

25.26

5Y Avg

324.62

BEAT

HeartBeam, Inc.

vs BDMD

Market Cap

$32.42M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BDMD

Market Cap

$33.61M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCLX

Scilex Holding Company

vs BDMD

Market Cap

$33.63M

PS Ratio

1.06

TTM Avg

1.75

3Y Avg

2.45

5Y Avg

15.95

NSYS

Nortech Systems Incorporated

vs BDMD

Market Cap

$31.52M

PS Ratio

0.25

TTM Avg

0.27

3Y Avg

0.24

5Y Avg

0.25

ELUT

Elutia Inc

vs BDMD

Market Cap

$34.35M

PS Ratio

2.83

TTM Avg

2.34

3Y Avg

2.93

5Y Avg

2.48

ARAY

Accuray Incorporated

vs BDMD

Market Cap

$31.11M

PS Ratio

0.08

TTM Avg

0.16

3Y Avg

0.35

5Y Avg

0.48

CRVO

CervoMed Inc.

vs BDMD

Market Cap

$30.92M

PS Ratio

95.87

TTM Avg

131.68

3Y Avg

131.68

5Y Avg

131.68

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Baird Medical Investment Holdings Limited (BDMD)	$32.93M	N/A	N/A	N/A	N/A
Nephros, Inc. (NEPH)vs ›	$32.79M	1.58	2.43	1.99	2.26
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.29M	1.06	22.78	25.26	324.62
HeartBeam, Inc. (BEAT)vs ›	$32.42M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$33.61M	N/A	N/A	N/A	N/A
Scilex Holding Company (SCLX)vs ›	$33.63M	1.06	1.75	2.45	15.95
Nortech Systems Incorporated (NSYS)vs ›	$31.52M	0.25	0.27	0.24	0.25
Elutia Inc (ELUT)vs ›	$34.35M	2.83	2.34	2.93	2.48
Accuray Incorporated (ARAY)vs ›	$31.11M	0.08	0.16	0.35	0.48
CervoMed Inc. (CRVO)vs ›	$30.92M	95.87	131.68	131.68	131.68

How this was calculated

The four-quarter calculation detail is unavailable for this stored observation.

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

BDMD PS Ratio Metrics

BDMD Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics